Ladenburg Thalmann Financial Services’s ALPS Medical Breakthroughs ETF SBIO Stock Holding History
Bought
Maintained
Sold
Other funds holding SBIO
ASN
CCP
NAM
CT
Ladenburg Thalmann Financial Services's SBIO Position: Q4 2019 in Review
Ladenburg Thalmann Financial Services increased its ALPS Medical Breakthroughs ETF (SBIO) stake by 11% in Q4 2019, buying an estimated $24.2K and bringing the position to 6,727 shares worth $284K. The position accounts for ﹤0.01% of the portfolio, ranked #2243.
Ladenburg Thalmann Financial Services first reported a position in SBIO in Q1 2015 and has held it in 20 quarters since. The position peaked at $344K in Q3 2018. 51 funds tracked by Wall St. Rank hold SBIO as of Q4 2019.
- Ladenburg Thalmann Financial Services held 6,727 shares of ALPS Medical Breakthroughs ETF worth $284K as of Q4 2019.
- Ladenburg Thalmann Financial Services bought 652 ALPS Medical Breakthroughs ETF shares in Q4 2019, an estimated $24.2K.
- ALPS Medical Breakthroughs ETF made up ﹤0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #2243 holding.
- Ladenburg Thalmann Financial Services first reported a position in ALPS Medical Breakthroughs ETF in Q1 2015 and has held it in 20 quarters since.
- Ladenburg Thalmann Financial Services's ALPS Medical Breakthroughs ETF position peaked at $344K in Q3 2018.
- 51 funds tracked by Wall St. Rank held ALPS Medical Breakthroughs ETF as of Q4 2019.
Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.